Prevention of acute mountain sickness by acetazolamide: As yet an unfinished story

Journal of Applied Physiology

Volumn 102, Issue 4, 2007, Pages 1305-1307

  Swenson, Erik R ^a   Teppema, Luc J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; SULFONAMIDE;

ALTITUDE DISEASE; BLOOD BRAIN BARRIER; BLOOD FLOW; CHEMORECEPTOR; DRUG PENETRATION; EDITORIAL; HUMAN; HYPERVENTILATION; HYPOXIA; INTRACRANIAL PRESSURE; METABOLIC ACIDOSIS; METABOLIC RATE; PRIORITY JOURNAL;

ACETAZOLAMIDE; ADAPTATION, PHYSIOLOGICAL; ALTITUDE SICKNESS; CARBONIC ANHYDRASE INHIBITORS; HUMANS; OXYGEN; OXYGEN CONSUMPTION;

EID: 34147179592     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01407.2006     Document Type: Editorial

References (18)

1. Ainslie PN, Burgess K, Subedi P, Burgess KR. Alterations in cerebral dynamics at high altitude following partial acclimatization in humans: wakefulness and sleep. J Appl Physiol 102: 658-664, 2007.
2. Bashir Y, Kann M, Stradling JR. The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects. Pulm Pharmacol 3: 151-154, 1990.
3. Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90: 13-24, 2005.
4. Forwand SA, Landowne M, Follansbee JN, Hansen JE. Effect of acetazolamide on acute mountain sickness. N Engl J Med 279: 839-845, 1968.
5. Hackett PH, Roach RC, Harrison GL, Schoene RB, Wills WJ. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 135: 896-898, 1987.
6. Hohne C, Pickerodt PA, Francis RC, Boemke W, Swenson ER. Pulmonary vasodilation by acetazolamide during hypoxia is not related to carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 292: L178-L184, 2007.
7. Huang SY, Mccullough RE, Mccullough RG, Micco AJ, Mancojohnson M, Weil JV, Reeves JT. Usual clinical dose of acetazolamide does not alter cerebral blood-flow velocity. Respir Physiol 72: 315-326, 1988.
8. Klocke RA. Potential role of endothelial carbonic anhydrase in dehydration of plasma bicarbonate. Trans Am Clin Climatol Assoc 108: 44-57, 1996.
9. Kronenberg RS, Cain SM. Effects of acetazolamide on physiologic and subjective responses of men to 14,000 feet. SAM-TR-67-81. School Aviat Med Tech Rep 67: 1-10, 1967.
10. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 102: 1313-1322, 2007.
11. 2 in unanesthetized dogs: central vs. peripheral chemoreceptors. J Appl Physiol 100: 13-19, 2006.
12. Swenson ER. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 12: 1242-1247, 1998
13. Swenson ER, Hughes JMB. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 74: 230-237, 1993.
14. Teppema LJ, Dahan A. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO2 sensitivity? Am J Respir Crit Care Med 160: 1592-1597, 1999.
15. Teppema LJ, Bijl H, Mousavi-Gourabi B, Dahan A. The carbonic anhydrase inhibitors methazolamide and acetazolamide have different effects on the hypoxic ventilatory response in the anaesthetized cat. J Physiol 574: 565-572, 2006.
16. Teppema LJ, Bijl H, Romberg R, Dahan A. Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol 572: 849-856, 2006.
17. Teppema LJ, Balanos GM, Steinback CD, Brown A, Foster G, Duff HJ, Leigh R, Poulin MJ. Effects of acetazolamide on ventilation, cerebrovascular and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med 175: 277-281, 2007.
18. Vogh BP. The relation of choroid plexus carbonic anhydrase activity to cerebro-spinal fluid formation: a study of three inhibitors in cat with extrapolation to man. J Pharmacol Exp Ther 213: 321-331, 1980.